Page 2 - Laurus Labs

Prospects in key segments to keep Laurus Labs' growth trajectory strong

The stock has seen a six-fold jump in value over the last one year

Laurus Labs rallies 5% on credit rating upgrade; stock hits record high

The company is looking to build new capacities/facilities that would propel its growth in the coming years

Laurus Labs gains 2% on robust growth outlook, zooms 70% so far in FY22

The company is looking to build new capacities and facilities that would propel its growth in the coming years

Laurus Labs, Alkyl Amines: More steam left after 1,000% gain from 2020 low?

Laurus Labs is likely to maintain its upward journey as long as it doesn't break the support level of Rs 600 levels

Laurus Labs trades higher for 8th straight day, soars 73% in 3 months

Shares of Laurus Labs continued their upward journey to hit a new high of Rs 599 on the BSE in intra-day trade on Tuesday

Laurus Labs shares advance 5% on strong growth outlook

Laurus is well poised to follow the success story of some leading CDMO players backed by strong chemistry and integrated model

Laurus Labs hits new high in subdued market, surges 30% in a month

The company is scheduled to meet on April 29, 2021, to consider and approve the audited financial results of the company for the financial year ended March 31, 2021

Laurus Labs rallies 6%, hits record high on heavy volume

The pharmaceutical company's stock surpassed its previous high of Rs 386, touched on January 25, 2021

Dixon Tech, Adani Green: How to trade multi-baggers of FY21 in new fiscal

Hindustan Copper, Aarti Drugs, Dixon Technology, APL Apollo Tubes, Laurus Labs and Affle India, meanwhile, zoomed over 400 per cent during FY21

Laurus Labs falls 5% as promoters sell 1.3% stake in company

Laurus Labs said the significant part of the above amount shall be utilized to release the pledge on their equity shares of the company

Select pharma shares rally; Suven Pharma up 13%, Laurus nears record high

Healthcare companies to post decent growth in revenues in Q3FY21

BSE Healthcare index hits new high; Sun Pharma, Laurus Labs gain up to 5%

Sun Pharmaceutical Industries hit afresh 52-week high of Rs 568.50, up nearly 4 per cent in the intra-day trade today. It has surged 11 per cent in the past four trading days on the BSE

Surprise amid pandemic: Firms across sectors beat Q2 earnings expectations

Most brokerages have revised upwards their earnings estimates, not only for FY21, but also for FY22

Laurus Labs gains 7% in two days on acquisition of Richcore Lifesciences

Motilal Oswal Securities maintains 'buy' rating on Laurus Labs with target price of Rs 410 per share

Laurus Labs gains 5% on acquisition of Richcore Lifesciences

Laurus Labs has signed a definitive agreement to acquire 72.55 per cent of Richcore's shares from Eight Roads Ventures and VenturEast for a value of Rs. 246.7 crore

Laurus Labs inks deal to buy majority stake in Richcore for Rs 247 crore

Following the successful closure of thetransaction, Richcore will be renamed as Laurus Bio Pvt Ltd, it added

Street rewards all but one of 12 companies that pruned share pledges

Sequent Scientific and Everyday Industries saw percentage shareholding pledged by promoters go down by over 44 per cent each and their shares rally by 68 per cent and 75 per cent, respectively

Adani Green Energy, Laurus Labs among top value creators in Samvat 2076

Meanwhile, Dr Reddy's Laboratories, Cipla, Infosys, HCL Technologies were up between 25 per cent and 75 per cent.

Laurus Labs extends fall for fourth straight day, dips 21% from record high

The company's profit after tax (PAT) was up 328 per cent year-on-year (YoY) at Rs 242 crore.

Street signs: Market trend turns weak, Laurus Labs stock rises, and more

After a sustained bull run, the markets are expected to enter a turbulent period